Live feed17:05:11·72dINSIDERFilingvia QuantisnowChief Scientific Officer Mahaney Paige was granted 240,000 shares, converted options into 7,050 shares and covered exercise/tax liability with 2,446 shares, increasing direct ownership by 239% to 336,910 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CCCC· C4 Therapeutics Inc.Health CareOriginal source